This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Ucbbiopharma Srl, Ucb Biopharma Sprl. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2025
Title: Christoph Meier: Innovator in Antibody Therapeutics
Introduction
Christoph Meier is a notable inventor based in Slough, GB. He has made significant contributions to the field of antibody therapeutics, holding a total of 3 patents. His work focuses on innovative solutions that address critical medical needs.
Latest Patents
Among his latest patents are the Anti-FcRn antibodies. The disclosure relates to antibodies specific to FcRn, formulations comprising the same, use of each in therapy, processes for expressing and optionally formulating said antibody, DNA encoding the antibodies, and hosts comprising said DNA. This innovative approach has the potential to impact therapeutic strategies significantly.
Career Highlights
Christoph has worked with prominent companies in the biopharmaceutical sector, including UCB Biopharma Srl and UCB Biopharma Sprl. His experience in these organizations has allowed him to develop and refine his expertise in antibody research and development.
Collaborations
Some of his notable coworkers include Helene Margaret Finney and Alastair David Griffiths Lawson. Their collaborative efforts have contributed to advancements in the field of antibody therapeutics.
Conclusion
Christoph Meier's work in the development of Anti-FcRn antibodies showcases his innovative spirit and dedication to improving therapeutic options. His contributions to the field are noteworthy and continue to influence the landscape of medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile